Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
Blog
Introducing Networks 2.0: Part One
This is part one of a four-part blog series on Networks in workers’ comp. Introducing Networks 2.0 Most discussions about the state of U.S.
Mitchell
News Release
Webcast: Workers' Compensation Legislation Addressing Essential Workers Affected by COVID-19
Mitchell
News Release
COVID-19 P&C Industry Regulatory Compliance Dashboard
The COVID-19 pandemic has generated an unprecedented volume of regulatory updates for the workers' compensation and auto casualty industries.
Mitchell
Virtual Event
AASCIF Connection Series: Touch-Less Claims: The Future of Technology and Automation in Workers' Compensation
On-Demand
Automation has the potential to continue to make major improvements to the workers’ compensation industry in terms of efficiency, consistency and m
Auto Casualty
Virtual Event
PLRB Webinar: Auto Casualty Claims Management Technologies
On-Demand
Technology is evolving at an ever-increasing pace.
Mitchell
News Release